LY686017: Clinical Trials

1 trial of LY686017, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow LY686017: new trials by email Literature Review of LY686017 trials Research Report on LY686017

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Tradipitant, Placebo - Nausea and Vomiting, Obesity
Phase 3RecruitingVanda Pharmaceuticals2802026-03-272026-04-20

Conditions studied

Nausea (1)  ·  Obesity (1)  ·  Vomiting (1)

Sponsors

Vanda Pharmaceuticals (1)

Countries

United States (1)